Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zagociguat in Alzheimer's Disease with Vascular Pathology
NCT04798989Phase 2Terminated
- Sponsor
- Tisento Therapeutics
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zagociguat in Alzheimer's disease (AD), sponsored by Tisento Therapeutics. Started Nov 2021; status: terminated.
02
Drugs
zagociguat
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT04798989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04798989.